NCT00667069 2025-06-05
Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer
UNICANCER
Phase 3 Completed
UNICANCER
University College, London
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Radiation Therapy Oncology Group
University of Texas Southwestern Medical Center
UNICANCER
European Organisation for Research and Treatment of Cancer - EORTC
Vanderbilt University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
OHSU Knight Cancer Institute